Gilead provides free drugs to Georgia to support hepatitis C research

Source: dingxiangyuan 2015-4-27 Geely is striving to prove to governments and global multilateral institutions that hepatitis C can be completely cured The company is carrying out a demonstration project in Georgia to provide free drugs for patients in need This unprecedented program will make the whole Caucasus a testing platform for the elimination of hepatitis C, using the high-efficiency and expensive tablet sovaldi from Gilead and its newly approved new product harvoni Georgia is the third highest incidence area of hepatitis C in the world, with the prevalence rate second only to Egypt and Mongolia Nearly 7% of adults carry hepatitis C virus There are also a wide range of virus variants and different types of patients in this area More importantly, Alton, head of business and medical affairs at the US pharmaceutical company, said the country is on a manageable scale, with a population of about 5 million and a virus screening system, making it an ideal place for scientific research "This is a very good country for research assessment," Alton said in a telephone interview at the annual meeting of liver research held in Vienna on the 22nd Supported by the Centers for Disease Control and prevention, the program will first recruit 5000 patients in 2015, and the second phase will recruit up to 20000 patients in one year Gilead's hepatitis C drug, a competitor of ABB vie, can cure hepatitis C, but the price in the west is far beyond the reach of poor countries In the United States, a piece of sovaldi costs 1000 dollars Gilead has already cut prices in low-income countries It needs $300 for a bottle of 28 pills It also wants to participate in international aid to eradicate hepatitis C widely "We're going to take Georgian data around the world and really eradicate disease over time," said Alton Alton acknowledged that the program could lead other governments to ask for free drugs, but pointed out that it was unrealistic to simply give up global products Instead, he wants to see global funds follow the International Foundation's lead in fighting AIDS, tuberculosis and malaria "Gilead cannot cure hepatitis C alone Other institutions have to be involved in making such investments, "he said.